w66国际·利来(中国)最给力的老牌
About Us
About Sino Biopharm
Board of Directors
Senior Management
R&D
R&D Team
Products
Product List
Sustainability
ESG Governance
ESG Management Practices
ESG Reports
Investors
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
News
Press Releases
Contact
CN
EN
Investors
Home
>
Investors
>
Corporate Governance
Information Disclosure
Corporate Governance
Presentation
Investor FAQ
Notices
Corporate Governance
Audit Committee
2022.01.05
Remuneration Committee
2022.01.05
Nomination Committee
2022.01.05
Existing Articles of Association
2022.06.06
Proposed amended and restated articles of association (clean version)
2025.04.22
Proposed amended and restated articles of association (blacklined version)
2025.04.22
List of Directors and Their Roles and Functions
2022.11.21
Board Diversity Policy
2021.07.14
1
2